Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 22.23B | 22.25B | 21.83B | 16.56B | 6.40B | 5.83B |
Gross Profit | 6.77B | 5.46B | 6.15B | 2.80B | -1.62B | -2.31B |
EBITDA | 2.95B | 3.04B | 4.83B | 1.00B | -1.65B | -2.39B |
Net Income | 1.70B | 1.72B | 2.28B | -1.70B | -3.60B | -4.65B |
Balance Sheet | ||||||
Total Assets | 31.95B | 31.21B | 30.20B | 29.51B | 30.61B | 28.91B |
Cash, Cash Equivalents and Short-Term Investments | 7.09B | 6.98B | 8.55B | 7.99B | 8.80B | 7.50B |
Total Debt | 12.73B | 12.67B | 13.86B | 16.31B | 16.52B | 12.99B |
Total Liabilities | 29.96B | 28.82B | 29.40B | 31.06B | 30.61B | 27.20B |
Stockholders Equity | 1.99B | 2.39B | 796.00M | -1.55B | 9.00M | 1.72B |
Cash Flow | ||||||
Free Cash Flow | 1.07B | 1.29B | 2.76B | 796.00M | -2.64B | -3.56B |
Operating Cash Flow | 3.86B | 3.93B | 4.32B | 2.37B | -1.56B | -2.35B |
Investing Cash Flow | -1.51B | -1.36B | -1.83B | -2.50B | -1.87B | -733.00M |
Financing Cash Flow | -1.73B | -2.87B | -2.37B | -1.61B | 4.01B | 4.70B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $6.77B | 4.46 | 132.28% | ― | 0.24% | -23.10% | |
58 Neutral | HK$14.28B | 4.63 | -3.01% | 6.75% | 3.67% | -54.16% | |
― | $9.33B | 32.14 | 8.87% | ― | ― | ― | |
― | $12.08B | 43.40 | ― | ― | ― | ||
73 Outperform | C$1.03B | 25.64 | 5.12% | 1.11% | 8.59% | 242.80% | |
59 Neutral | C$592.50M | ― | -0.09% | ― | -17.58% | -703.93% | |
― | $1.15B | 13.36 | 15.65% | 1.36% | ― | ― |